K Number
K050603
Device Name
OLPUR DIALYZER, MODEL HD 190
Manufacturer
Date Cleared
2005-06-09

(92 days)

Product Code
Regulation Number
876.5860
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The OLpūr™ HD 190 Dialyzer is indicated for hemodialysis and hemodiafiltration of patients with acute or chronic renal failure.
Device Description
The OLpur"M HD 190 Dialyzer is a sterile, non-pyrogenic, single use, high permeability hemodialyzer intended to be used in providing hemodiafiltration to patients with acute or chronic renal failure. This dialyzer is designed for use only with UF controlled dialysis equipment and is compatible with all models of this generic type of equipment currently in use in the US. The individual dialyzers are packaged in a pouch constructed of Polyamide/Polyethylene film and a Tyvek® backing. The individually packaged dialyzers are packaged twelve to a carton and thirty-six to a shipping container. The dialyzer membranes used in this device consist of polyethersulfone (PES). The hollow fiber membranes are potted in a polyurethane compound at each end within a polycarbonate dialyzer casing to form a tubesheet. A polycarbonate blood inlet header attached to the end of the casing directs the incoming blood into the hollow fibers. The blood then flows through the inside of the hollow fibers and exits out through the polycarbonate blood outlet header attached to the other end of the casing. Inlet and outlet dialysate (Hansen) ports on the dialyzer casing allow for the flow of dialysate around the outside of the hollow fibers counter-current to the blood flow. Uremic toxins and excess plasma water are removed from the blood across the semi-permeable hollow fibers. A combination of diffusion, due to the concentration differences between the blood and dialysate, and convection, due to the transmembrane pressure differential across the hollow fibers, leads to the toxin removal. The spent dialysate exits the device via the dialysate outlet port. As received by the customer, the dialyzer's blood and dialysate ports are covered with polyethylene sterility caps. Silicone o-rings are included in the connections between the headers and the dialyzer tubesheet at each end of the dialyzer to provide a fluid-tight seal between the headers and the tubesheet.
More Information

Not Found

No
The device description focuses on the physical components and mechanism of action of a hemodialyzer, with no mention of software, algorithms, or data processing that would indicate the use of AI/ML.

Yes
The provided text explicitly states that the device is indicated for "hemodialysis and hemodiafiltration of patients with acute or chronic renal failure," which are therapeutic procedures aimed at treating a medical condition.

No
The document describes a hemodialyzer, which is a device used for treatment of renal failure by removing toxins and excess fluid from the blood. It is a therapeutic device, not a device used for diagnosing a condition.

No

The device description clearly details a physical medical device (dialyzer) with components like membranes, casing, headers, and ports, not a software-only product.

No, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • IVD Definition: In Vitro Diagnostic devices are used to examine specimens taken from the human body (like blood, urine, or tissue) outside of the body to provide information for diagnosis, monitoring, or screening.
  • Device Function: The OLpūr™ HD 190 Dialyzer is a hemodialyzer. Its function is to filter blood within a dialysis circuit connected to the patient's body. It removes waste products and excess fluid directly from the blood as it flows through the device.
  • Intended Use: The intended use is for "hemodialysis and hemodiafiltration of patients with acute or chronic renal failure." This is a therapeutic treatment, not a diagnostic test performed on a specimen.

The device description clearly outlines a process where blood flows through the device and is filtered, which is a direct interaction with the patient's blood in vivo (within the body) as part of a treatment, not an in vitro analysis of a sample.

N/A

Intended Use / Indications for Use

The OLpūr™ HD 190 Dialyzer is indicated for hemodialysis and hemodiafiltration of patients with acute or chronic renal failure.

Product codes

KDI

Device Description

The OLpur"M HD 190 Dialyzer is a sterile, non-pyrogenic, single use, high permeability hemodialyzer intended to be used in providing hemodiafiltration to patients with acute or chronic renal failure. This dialyzer is designed for use only with UF controlled dialysis equipment and is compatible with all models of this generic type of equipment currently in use in the US. The individual dialyzers are packaged in a pouch constructed of Polyamide/Polyethylene film and a Tyvek® backing. The individually packaged dialyzers are packaged twelve to a carton and thirty-six to a shipping container.

The dialyzer membranes used in this device consist of polyethersulfone (PES). The hollow fiber membranes are potted in a polyurethane compound at each end within a polycarbonate dialyzer casing to form a tubesheet. A polycarbonate blood inlet header attached to the end of the casing directs the incoming blood into the hollow fibers. The blood then flows through the inside of the hollow fibers and exits out through the polycarbonate blood outlet header attached to the other end of the casing. Inlet and outlet dialysate (Hansen) ports on the dialyzer casing allow for the flow of dialysate around the outside of the hollow fibers counter-current to the blood flow. Uremic toxins and excess plasma water are removed from the blood across the semi-permeable hollow fibers. A combination of diffusion, due to the concentration differences between the blood and dialysate, and convection, due to the transmembrane pressure differential across the hollow fibers, leads to the toxin removal. The spent dialysate exits the device via the dialysate outlet port.

As received by the customer, the dialyzer's blood and dialysate ports are covered with polyethylene sterility caps. Silicone o-rings are included in the connections between the headers and the dialyzer tubesheet at each end of the dialyzer to provide a fluid-tight seal between the headers and the tubesheet.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies

OLpur HD 190 Dialyzer was subjected to biocompatibility, sterility, pyrogenicity, shelf life, and in vitro performance testing to demonstrate its equivalence to the predicate devices. All of the testing supported the substantial equivalence by the test results. Both the subject devices and the predicate devices are effective as High Flux Hollow Fiber Hemodialyzers. Based on this data it was concluded that OLpur HD 190 Dialyzer is substantially equivalent to the Gambro Polyflux 21S Dialyzer and the Asahi APS 21R Dialyzer.

Key Metrics

Not Found

Predicate Device(s)

K982414, K001250

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 876.5860 High permeability hemodialysis system.

(a)
Identification. A high permeability hemodialysis system is a device intended for use as an artificial kidney system for the treatment of patients with renal failure, fluid overload, or toxemic conditions by performing such therapies as hemodialysis, hemofiltration, hemoconcentration, and hemodiafiltration. Using a hemodialyzer with a semipermeable membrane that is more permeable to water than the semipermeable membrane of the conventional hemodialysis system (§ 876.5820), the high permeability hemodialysis system removes toxins or excess fluid from the patient's blood using the principles of convection (via a high ultrafiltration rate) and/or diffusion (via a concentration gradient in dialysate). During treatment, blood is circulated from the patient through the hemodialyzer's blood compartment, while the dialysate solution flows countercurrent through the dialysate compartment. In this process, toxins and/or fluid are transferred across the membrane from the blood to the dialysate compartment. The hemodialysis delivery machine controls and monitors the parameters related to this processing, including the rate at which blood and dialysate are pumped through the system, and the rate at which fluid is removed from the patient. The high permeability hemodialysis system consists of the following devices:(1) The hemodialyzer consists of a semipermeable membrane with an in vitro ultrafiltration coefficient (K
uf ) greater than 8 milliliters per hour per conventional millimeter of mercury, as measured with bovine or expired human blood, and is used with either an automated ultrafiltration controller or anther method of ultrafiltration control to prevent fluid imbalance.(2) The hemodialysis delivery machine is similar to the extracorporeal blood system and dialysate delivery system of the hemodialysis system and accessories (§ 876.5820), with the addition of an ultrafiltration controller and mechanisms that monitor and/or control such parameters as fluid balance, dialysate composition, and patient treatment parameters (e.g., blood pressure, hematocrit, urea, etc.).
(3) The high permeability hemodialysis system accessories include, but are not limited to, tubing lines and various treatment related monitors (e.g., dialysate pH, blood pressure, hematocrit, and blood recirculation monitors).
(b)
Classification. Class II. The special controls for this device are FDA's:(1) “Use of International Standard ISO 10993 ‘Biological Evaluation of Medical Device—Part I: Evaluation and Testing,’ ”
(2) “Guidance for the Content of 510(k)s for Conventional and High Permeability Hemodialyzers,”
(3) “Guidance for Industry and CDRH Reviewers on the Content of Premarket Notifications for Hemodialysis Delivery Systems,”
(4) “Guidance for the Content of Premarket Notifications for Water Purification Components and Systems for Hemodialysis,” and
(5) “Guidance for Hemodialyzer Reuse Labeling.”

0

510(k) Summary

Submitter

Nephros, Inc. 3960 Broadway New York, NY 10032 USA

Contact:

Nadia C. Greenidge Manager of Quality Assurance and Regulatory Affairs

Phone: 212-781-5113 Fax: 212-781-5166

Date summary was prepared:

3/8/05

Name(s) of the device

OLpūr™ HD 190 Dialyzer

Identification of predicate device(s)

The OLpur HD 190 Dialyzer is substantially equivalent to the following devices:

Gambro Polyflux 21S Dialyzer, 510(k) # K982414

Asahi APS 21R Dialyzer, 510(k) # K001250

Description of the device

The OLpur"M HD 190 Dialyzer is a sterile, non-pyrogenic, single use, high permeability hemodialyzer intended to be used in providing hemodiafiltration to patients with acute or chronic renal failure. This dialyzer is designed for use only with UF controlled dialysis equipment and is compatible with all models of this generic type of equipment currently in use in the US. The individual dialyzers are packaged in a pouch constructed of Polyamide/Polyethylene film and a Tyvek® backing. The individually packaged dialyzers are packaged twelve to a carton and thirty-six to a shipping container.

The dialyzer membranes used in this device consist of polyethersulfone (PES). The hollow fiber membranes are potted in a polyurethane compound at each end within a polycarbonate dialyzer casing to form a tubesheet. A polycarbonate blood inlet header attached to the end of the casing directs the incoming blood into the hollow fibers. The blood then flows through the inside of the

1

Image /page/1/Picture/0 description: The image shows the text "K050603 PAGE 2 OF 2". The text appears to be handwritten. The text is black against a white background.

hollow fibers and exits out through the polycarbonate blood outlet header attached to the other end of the casing. Inlet and outlet dialysate (Hansen) ports on the dialyzer casing allow for the flow of dialysate around the outside of the hollow fibers counter-current to the blood flow. Uremic toxins and excess plasma water are removed from the blood across the semi-permeable hollow fibers. A combination of diffusion, due to the concentration differences between the blood and dialysate, and convection, due to the transmembrane pressure differential across the hollow fibers, leads to the toxin removal. The spent dialysate exits the device via the dialysate outlet port.

As received by the customer, the dialyzer's blood and dialysate ports are covered with polyethylene sterility caps. Silicone o-rings are included in the connections between the headers and the dialyzer tubesheet at each end of the dialyzer to provide a fluid-tight seal between the headers and the tubesheet.

Intended Use

The OLDur™ HD 190 Dialyzer is indicated for hemodialysis and hemodiafiltration of patients with acute or chronic renal failure.

Comparison of device characteristics to predicate

The OLour HD 190 Dialyzer is substantially equivalent to the Gambro Polyflux 21S, in that they are both sterile, single use, high permeability hemodialyzers with the same intended use, of similar construction, made with the same type of membrane material and comparable in regard to their performance characteristics.

The OLDur HD 190 Dialyzer is also substantially equivalent to the Asahi APS 21R in that they are both sterile, high permeability hemodialyzers with similar intended use, of similar construction and materials, made with the same type of membrane material and comparable in regard to their performance characteristics.

Nonclinical testing

OLpur HD 190 Dialyzer was subjected to biocompatibility, sterility, pyrogenicity, shelf life, and in vitro performance testing to demonstrate its equivalence to the predicate devices. All of the testing supported the substantial equivalence by the test results. Both the subject devices and the predicate devices are effective as High Flux Hollow Fiber Hemodialyzers. Based on this data it was concluded that OLpur HD 190 Dialyzer is substantially equivalent to the Gambro Polyflux 21S Dialyzer and the Asahi APS 21R Dialyzer,

Conclusion

Based on the descriptive information and performance data provided in this premarket notification, it is concluded that the OLpur HD 190 Dialyzer is substantially equivalent to the predicate devices listed above.

2

ﺮ ﻋ

Image /page/2/Picture/2 description: The image shows a logo with a circular border containing text, and an abstract graphic in the center. The graphic appears to be a stylized representation of an eagle or bird in flight, with three curved lines suggesting movement or feathers. The text around the border is partially obscured but seems to be part of an official seal or emblem.

JUN 9 - 2005

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

Ms. Nadia Greenidge Manager QA/RA Nephros, Inc. 3960 Broadway NEW YORK NY 10032

Re: K050603

Trade/Device Name: Nephrol OLpūr™ HD 190 Dialyzer Regulation Number: 21 CFR §876.5860 Regulation Name: High permeability hemodialysis system Regulatory Class: II Product Code: KDI Dated: May 26, 2005 Received: May 27, 2005

Dear Ms. Greenidge:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced we nave reviewed your becalled in oppy probstantially equivalent (for the indications for use stated in above and have decemined the ad predicate devices marketed in interstate commerce prior to the enclosule) to tegarry mattered produced Device Amendments, or to devices that have been May 20, 1970, the clascinonic dato of the Federal Food, Drug, and Cosmetic Act (Act) that recrassified in accordation warmatics approval application (PMA). You may, therefore, market the do not require approval or a premiation of the Act. The general controls provisions of the Act device, subjost to the gatedal controls provinces, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket If your device is classified (300 additional controls. Existing major regulations affecting your Apployal), it may of subject to such aderal Regulations, Title 21, Parts 800 to 898. In addition, FDA ucvice can be round in the concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that Please or advised that I DA 3 issualled of a sice complies with other requirements of the Act of all Federal statutes and regulations administered by other Federal agencies. You must comply with all the Federal statues and regulations administer of registration and listing (21 CFR Part 807); labeling Act s requirements, modulity, but hot million is regultements as set forth in the quality systems (QS) (ZF CFR Part 801); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act): 21 CFR 1000-1050.

3

This letter will allow you to begin marketing your device as described in your Section 510(k) I mo lotter with cation. The FDA finding of substantial equivalence of your device to a legally promatics notificate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please 11 you don't office of Compliance at one of the following numbers, based on the regulation number at the top of this letter:

21 CFR 876.xxxx(Gastroenterology/Renal/Urology)240-276-0115
21 CFR 884.xxxx(Obstetrics/Gynecology)240-276-0115
21 CFR 892.xxxx(Radiology)240-276-0120
Other-240-276-0100

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Anot produs neve the regulation on your responsibilities under the Act from the 60 : 77). " Ca may obtain ourers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

Nancy C. Hogdon

Nancy C. Brogdon Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

4

Indications for Use

510(k) Number: K050603

Device Name: OLpūr™ HD 190 Dialyzer

Indications For Use:

The OLpūr™ HD 190 Dialyzer is indicated for hemodialysis and hemodiafiltration of patients with acute or chronic renal failure.

Prescription Use

AND/OR

Over-The-Counter Use

(Part 21 CFR 801 Subpart D)

(21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Colin m Pollard

(Division Sign-Off) Division of Reproductive, Abdominal and Radiological Device 510(k) Number.